Wait for final pricing and size of the offering before taking a position. The stock may decline on the announcement of larger-than-expected dilution. Monitor the prospectus supplement for definitive terms and the NASDAQ filing for pricing details.
Price Chart
Executive Summary
InflaRx filed a preliminary prospectus supplement for an underwritten offering of ordinary shares. The size and pricing are not yet disclosed, but the company will use proceeds to advance pipeline activities and for working capital. Existing shareholders will face dilution, and the filing is preliminary with many placeholder amounts.
Key Facts
- Offering of ordinary shares, size and price not disclosed (preliminary filing)
- As of March 31, 2026, net tangible book value was $41.5M ($0.57/share) on 72,292,859 shares outstanding
- Last sale price on May 5, 2026 was $1.97 per share
- Company had total funds available of €39.7M as of March 31, 2026
- Proceeds to fund pipeline activities and working capital; cash runway projected through 2029
- Restructuring announced in January 2026; CMO resigned effective August 2026
Financial Impact
Offering size and price not yet determined; dilution will depend on final terms
Risk Factors
- Significant dilution to existing shareholders
- Uncertainty around offering size and pricing
- Pre-revenue biotech with ongoing cash burn and restructuring
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001140361-26-019288 |
| Document: 0001140361-26-019288-index-headers.html | 0001140361-26-019288 |
| Document: 0001140361-26-019288-index.html | 0001140361-26-019288 |
| Document: 0001140361-26-019288.txt | 0001140361-26-019288 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $1.56 | awaiting T+20 | — | $1.58 (+0.96%) |
Oct 22, 2026 4d ago | Press Release | $1.53 | awaiting T+20 | — | $1.58 (+2.94%) |
Oct 2, 2026 24d ago | Press Release | $1.72 | awaiting T+20 | — | $1.58 (−8.43%) |
Oct 1, 2026 25d ago | Press Release | $1.71 | awaiting T+20 | — | $1.58 (−7.89%) |
Aug 14, 2026 10w ago | 424B5 | $2.07 $2.02 | ▲ +2.42% | ▲ +0.44% | $1.58 (+23.91%) |
Aug 13, 2026 10w ago | EFFECT | $2.01 $2.09 | ▼ −3.98% | ▼ −5.73% | $1.58 (+21.64%) |
Aug 6, 2026 11w ago | 6-K | $1.72 $2.23 | ▲ +29.65% | ▲ +29.05% | $1.58 (−8.43%) |
Jun 30, 2026 16w ago | 6-K | $2.33 $1.65 | ▼ −29.18% | ▼ −27.00% | $1.58 (−32.40%) |
Jun 30, 2026 16w ago | Press Release | $2.24 $1.70 | ▼ −24.11% | ▼ −23.08% | $1.58 (−29.69%) |
May 6, 2026 24w ago | 424B5 | $2.65 $2.06 | ▲ +22.26% | ▲ +25.40% | $1.58 (+40.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers